| 000 | 01574 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518091001.0 | ||
| 264 | 0 | _c20200525 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1522-1539 | ||
| 024 | 7 |
_a10.1152/ajpheart.00538.2019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBryson, Timothy D | |
| 245 | 0 | 0 |
_aThe deleterious role of the prostaglandin E _h[electronic resource] |
| 260 |
_bAmerican journal of physiology. Heart and circulatory physiology _c04 2020 |
||
| 300 |
_aH867-H882 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiotensin II _xtoxicity |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDinoprostone _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Prostaglandin E, EP3 Subtype _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 700 | 1 | _aPandrangi, Teja S | |
| 700 | 1 | _aKhan, Safa Z | |
| 700 | 1 | _aXu, Jiang | |
| 700 | 1 | _aPavlov, Tengis S | |
| 700 | 1 | _aOrtiz, Pablo A | |
| 700 | 1 | _aPeterson, Edward | |
| 700 | 1 | _aHarding, Pamela | |
| 773 | 0 |
_tAmerican journal of physiology. Heart and circulatory physiology _gvol. 318 _gno. 4 _gp. H867-H882 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajpheart.00538.2019 _zAvailable from publisher's website |
| 999 |
_c30712983 _d30712983 |
||